體外循環機市場規模、佔有率和成長分析：按產品類型、組件、應用、最終用戶、患者類型、技術和地區分類－2026-2033年產業預測

2024 年全球體外循環機市值為 4.4 億美元，預計到 2033 年將成長至 6.9438 億美元，而 2025 年為 4.6288 億美元，預測期（2026-2033 年）複合年成長率為 5.2%。

全球體外循環市場的主要促進因素是心臟病盛行率的上升、人口老化以及心血管手術日益複雜，需要更先進的輔助設備。體外膜氧合（ECMO）系統正從大型固定式設備轉型為攜帶式解決方案，尤其是在呼吸支援需求不斷成長的情況下。這種轉變促使ECMO在成人心臟衰竭和兒童呼吸系統疾病的應用日益廣泛，從而縮短住院時間並降低醫療成本。人工智慧驅動的自動化等創新技術透過實現即時數據分析和封閉回路型控制，最大限度地減少人為錯誤，並支援遠端監測，從而提高了效率。這些進步不僅改善了患者的治療效果，也為醫療設備製造商和服務公司在不斷變化的醫療保健環境中創造了新的商機。

全球體外循環市場成長要素

隨著嚴重心臟衰竭衰竭發病率的上升，醫療機構正加大對先進體外循環機的投資，這些機器在重症監護中發揮著至關重要的作用。醫療專業人員越來越關注能夠提供可靠循環支援的技術，醫療機構也將資源投入這些關鍵設備。隨著人們對這些技術治療益處的認知不斷加深，患者轉診量也在增加，這進一步推動了對這些能夠提高生存率和促進術後康復的先進系統的需求。此外，醫療機構也在努力滿足優先考慮先進救生技術的認證要求，這進一步強化了市場上的採購趨勢。

全球體外循環市場面臨的限制因素

先進的體外循環機需要大量的資金投入，這對許多醫療機構，尤其是資源有限的機構來說，構成了一項挑戰。預算限制迫使醫院將重點放在基本服務上，這往往導致高成本生命支持技術的引進被延遲或限制。此外，持續的維護和耗材成本也增加了整體支出，使得小規模的醫療機構對採用最新技術猶豫不決。儘管這些先進設備具有顯著的臨床益處，但這些經濟負擔限制了市場擴張並阻礙了成長。因此，醫療決策者往往更傾向於成熟且價格更實惠的替代方案，導致對尖端解決方案的需求下降。

全球體外循環市場趨勢

全球體外循環市場正經歷著一場變革性趨勢，而人工智慧 (AI) 與灌注管理的融合正是推動這一趨勢的關鍵因素。這項技術進步使臨床醫生能夠利用即時數據分析，預測性地調整血流速度、氧合水平和抗凝血參數，從而顯著提高患者安全，同時最大限度地減少人工干預。隨著精準醫療的日益普及，對人工智慧增強型體外循環機的需求不斷成長，這些設備如今已成為現代外科手術中不可或缺的工具。這種轉變不僅增強了外科團隊之間的信任，也推動了研發投入的增加，並在新興市場和成熟市場中促進了醫療技術生態系統內的夥伴關係。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球體外循環機市場規模：依產品類型分類

• 體外循環機
• 心肺體外迴圈（CPB）系統
• 體外循環系統
• 可攜式灌注系統
• 整合灌注工作站

全球體外循環機市場規模：依組件分類

• 主機系統
• 泵浦
  • 滾筒幫浦
  • 離心式幫浦
• 氧合器
• 水庫
• 監控系統
• 導管和一次性套裝

全球體外循環機市場規模：依應用領域分類

• 冠狀動脈繞道手術手術（CABG）
• 心臟瓣膜手術
• 先天性心臟疾病手術
• 心臟移植
• 肺移植
• 其他開胸手術

全球體外循環機市場規模：依最終用戶分類

• 醫院
• 心臟醫療中心
• 大學醫院

全球體外循環機市場規模：依病患類型分類

• 成人
• 兒童
• 新生

全球體外循環機市場規模：依技術分類

• 傳統體外循環系統
• 小型化體外循環系統
• 整合灌注平台

全球體外循環機市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Getinge
• LivaNova
• Terumo Corporation
• XENIOS AG
• Braile Biomedica
• Medtronic
• Senko Medical Instrument
• Tianjin Medical
• Nipro Corporation
• Eurosets
• HEMOVENT
• Chongqing PSK-HealthSci Tech
• Kewei Medical Apparatus
• Tianjin Plastics Research Institute Medical Devices
• Sarns Medical
• Spectrum Medical
• Jostra
• MERA（Senko Medical Instrument）
• Sorin Group Italia
• Stockert

結論與建議

Global Artificial Heart Lung Machine Market size was valued at USD 440.0 Million in 2024 and is poised to grow from USD 462.88 Million in 2025 to USD 694.38 Million by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The global artificial heart-lung machine market is primarily driven by the rising prevalence of heart disease, an aging population, and the complexity of cardiac procedures necessitating advanced support. Extracorporeal membrane oxygenation (ECMO) systems have transformed from large, stationary units to portable solutions, especially in light of heightened demand for respiratory assistance. This shift has led to an increase in ECMO utilization for adult heart failure and pediatric respiratory issues, thereby shortening hospital stays and reducing costs. Innovations like AI-driven automation are enhancing efficiency by enabling real-time data analytics and closed-loop control, minimizing human error and allowing remote monitoring. These advancements not only improve patient outcomes but also create new revenue opportunities for device manufacturers and service firms in the evolving healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Heart Lung Machine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Heart Lung Machine Market Segments Analysis

Global artificial heart lung machine market is segmented by product type, component, application, end user, patient type, technology and region. Based on product type, the market is segmented into Heart-Lung Machines, Cardiopulmonary Bypass (CPB) Systems, Extracorporeal Circulation Systems, Portable Perfusion Systems and Integrated Perfusion Workstations. Based on component, the market is segmented into Console Systems, Pumps, Oxygenators, Reservoirs, Monitoring Systems and Tubing & Disposable Sets. Based on application, the market is segmented into Coronary Artery Bypass Grafting (CABG), Heart Valve Surgery, Congenital Heart Surgery, Heart Transplantation, Lung Transplantation and Other Open-heart Procedures. Based on end user, the market is segmented into Hospitals, Cardiac Specialty Centers and Academic Medical Centers. Based on patient type, the market is segmented into Adult, Pediatric and Neonatal. Based on technology, the market is segmented into Conventional CPB Systems, Miniaturized CPB Systems and Integrated Perfusion Platforms. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Heart Lung Machine Market

The rising incidence of severe cardiac and respiratory failure is prompting healthcare facilities to invest in advanced artificial heart-lung machines, which play a crucial role in providing support to patients during critical care procedures. Healthcare professionals are increasingly focused on technologies that offer dependable circulatory assistance, leading organizations to allocate resources towards these essential devices. As understanding of their treatment advantages grows, the number of patient referrals increases, further boosting the demand for these advanced systems that enhance survival rates and postoperative recovery. Additionally, institutions aim to comply with accreditation requirements that prioritize advanced life-support technologies, thereby reinforcing procurement trends in the market.

Restraints in the Global Artificial Heart Lung Machine Market

The significant financial investment needed for advanced artificial heart-lung machines poses a challenge for many healthcare facilities, especially those operating with limited resources. Budget constraints compel hospitals to focus on essential services, which often results in the postponement or restriction of acquiring high-cost life-support technologies. Furthermore, the continuous maintenance and consumable costs add to the overall expense, deterring smaller institutions from embracing newer innovations. This economic strain limits market expansion and hinders growth, despite the clinical benefits provided by these advanced devices. As a result, healthcare decision-makers may favor established, more affordable alternatives, leading to a decreased demand for state-of-the-art solutions.

Market Trends of the Global Artificial Heart Lung Machine Market

The Global Artificial Heart Lung Machine market is witnessing a transformative trend driven by the integration of artificial intelligence in perfusion management. This advancement empowers clinicians to utilize real-time data analytics for predictive adjustments in flow rates, oxygenation levels, and anticoagulation parameters, significantly enhancing patient safety while minimizing manual intervention. The growing emphasis on precision medicine is leading to an increased demand for AI-enhanced heart-lung machines, which are now seen as essential tools in modern surgical settings. This shift not only fosters confidence among surgical teams but also stimulates greater research and development investments and collaborative partnerships within the med-tech ecosystem across both emerging and mature market regions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Artificial Heart Lung Machine Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Heart-Lung Machines
• Cardiopulmonary Bypass (CPB) Systems
• Extracorporeal Circulation Systems
• Portable Perfusion Systems
• Integrated Perfusion Workstations

Global Artificial Heart Lung Machine Market Size by Component & CAGR (2026-2033)

• Market Overview
• Console Systems
• Pumps
  • Roller Pumps
  • Centrifugal Pumps
• Oxygenators
• Reservoirs
• Monitoring Systems
• Tubing & Disposable Sets

Global Artificial Heart Lung Machine Market Size by Application & CAGR (2026-2033)

• Market Overview
• Coronary Artery Bypass Grafting (CABG)
• Heart Valve Surgery
• Congenital Heart Surgery
• Heart Transplantation
• Lung Transplantation
• Other Open-heart Procedures

Global Artificial Heart Lung Machine Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Specialty Centers
• Academic Medical Centers

Global Artificial Heart Lung Machine Market Size by Patient Type & CAGR (2026-2033)

• Market Overview
• Adult
• Pediatric
• Neonatal

Global Artificial Heart Lung Machine Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Conventional CPB Systems
• Miniaturized CPB Systems
• Integrated Perfusion Platforms

Global Artificial Heart Lung Machine Market Size & CAGR (2026-2033)

• North America (Product Type, Component, Application, End User, Patient Type, Technology)
  • US
  • Canada
• Europe (Product Type, Component, Application, End User, Patient Type, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Component, Application, End User, Patient Type, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Component, Application, End User, Patient Type, Technology)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Component, Application, End User, Patient Type, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Getinge
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• XENIOS AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Senko Medical Instrument
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tianjin Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurosets
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HEMOVENT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chongqing PSK-HealthSci Tech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kewei Medical Apparatus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tianjin Plastics Research Institute Medical Devices
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sarns Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spectrum Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jostra
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MERA (Senko Medical Instrument)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sorin Group Italia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stockert
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations